Cabot Co. (NYSE:CBT) Shares Sold by Dynamic Technology Lab Private Ltd

Dynamic Technology Lab Private Ltd reduced its holdings in shares of Cabot Co. (NYSE:CBT - Free Report) by 70.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,421 shares of the specialty chemicals company's stock after selling 22,586 shares during the period. Dynamic Technology Lab Private Ltd's holdings in Cabot were worth $1,053,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the business. Wolff Wiese Magana LLC bought a new position in Cabot in the 3rd quarter worth $25,000. UMB Bank n.a. increased its position in Cabot by 53.9% in the third quarter. UMB Bank n.a. now owns 371 shares of the specialty chemicals company's stock worth $41,000 after buying an additional 130 shares in the last quarter. CWM LLC raised its stake in shares of Cabot by 60.6% in the second quarter. CWM LLC now owns 416 shares of the specialty chemicals company's stock worth $38,000 after buying an additional 157 shares during the period. Farther Finance Advisors LLC lifted its position in shares of Cabot by 197.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 417 shares of the specialty chemicals company's stock valued at $47,000 after buying an additional 277 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Cabot by 33.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 475 shares of the specialty chemicals company's stock valued at $48,000 after buying an additional 119 shares in the last quarter. 93.18% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have commented on CBT. Mizuho raised their target price on shares of Cabot from $103.00 to $122.00 and gave the stock an "outperform" rating in a research note on Tuesday, November 5th. UBS Group dropped their target price on shares of Cabot from $103.00 to $98.00 and set a "neutral" rating for the company in a report on Tuesday, August 6th. Finally, JPMorgan Chase & Co. cut Cabot from a "neutral" rating to an "underweight" rating and set a $105.00 price target on the stock. in a report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Cabot presently has an average rating of "Hold" and an average target price of $105.00.

Cabot Price Performance

CBT stock opened at $110.59 on Wednesday. The company has a market capitalization of $6.01 billion, a PE ratio of 16.41, a price-to-earnings-growth ratio of 0.97 and a beta of 1.20. The company's fifty day moving average price is $110.97 and its 200-day moving average price is $102.76. Cabot Co. has a one year low of $70.63 and a one year high of $117.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.36 and a current ratio of 2.08.

Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $1.80 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.81 by ($0.01). Cabot had a return on equity of 26.60% and a net margin of 9.51%. The firm had revenue of $1 billion during the quarter, compared to the consensus estimate of $1.01 billion. During the same period in the previous year, the firm earned $1.65 EPS. The business's revenue was up 3.7% compared to the same quarter last year. On average, equities analysts anticipate that Cabot Co. will post 7.67 EPS for the current fiscal year.

Cabot Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Friday, November 29th will be given a $0.43 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $1.72 annualized dividend and a yield of 1.56%. Cabot's dividend payout ratio is currently 25.52%.

Insiders Place Their Bets

In related news, CEO Sean D. Keohane sold 25,617 shares of the firm's stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total value of $2,601,406.35. Following the transaction, the chief executive officer now owns 331,174 shares of the company's stock, valued at $33,630,719.70. This trade represents a 7.18 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CAO Lisa M. Dumont sold 865 shares of Cabot stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $111.74, for a total value of $96,655.10. Following the sale, the chief accounting officer now directly owns 9,742 shares of the company's stock, valued at approximately $1,088,571.08. This trade represents a 8.15 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 75,807 shares of company stock valued at $8,352,941 over the last ninety days. 3.07% of the stock is owned by insiders.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.